Trifluoroacetic Acid

Trifluoroacetic Acid

SCHEMBL8798382

COc1ccc(-c2nc(-c3ccc(O)cc3)n(Cc3ccccc3)c2-c2ccc(OC)cc2)cc1.O=C(O)C(F)(F)F

nearest known ligand 0.54

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 8/20 0.54
▸ HTT P42858 5/20 0.54
▸ HPGD P15428 4/20 0.54
▸ SMN1; SMN2 Q16637 3/20 0.54
▸ MAPT P10636 3/20 0.54
▸ TP53 P04637 3/20 0.54
▸ NPSR1 Q6W5P4 2/20 0.54
▸ KDM4E B2RXH2 5/20 0.49
▸ LMNA P02545 2/20 0.49
▸ L3MBTL1 Q9Y468 2/20 0.49
▸ CNR2 P34972 1/20 0.49
▸ GAA P10253 5/20 0.48
▸ KMT2A Q03164 4/20 0.46
▸ MEN1 O00255 3/20 0.46
▸ MGAM O43451 2/20 0.45
▸ SI P14410 2/20 0.45
▸ MGAM2 Q2M2H8 2/20 0.45
▸ RECQL P46063 1/20 0.43
▸ PDE6D O43924 1/20 0.43
▸ MTOR P42345 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8798390 0.90 ALDH1A1 (0.54) ALDH1A1HTTHPGDSMN1; SMN2MAPT
SCHEMBL17956061 0.78 NPC1 (0.52) ALDH1A1HTTHPGDSMN1; SMN2MAPT
SCHEMBL9980465 0.77 KDM4E (0.47) ALDH1A1HTTHPGDSMN1; SMN2MAPT
SCHEMBL28096950 0.76 PPARG (0.51) ALDH1A1HTTHPGDSMN1; SMN2MAPT
SCHEMBL17955964 0.75 NPC1 (0.48) ALDH1A1HTTHPGDSMN1; SMN2MAPT
SCHEMBL2105872 0.75 NPC1 (0.46) ALDH1A1HTTSMN1; SMN2KDM4ELMNA
SCHEMBL17955991 0.75 DRD2 (0.46) ALDH1A1HTTHPGDSMN1; SMN2MAPT
SCHEMBL17955921 0.74 MAOB (0.45) ALDH1A1HTTSMN1; SMN2MAPTKDM4E
SCHEMBL27975918 0.74 TP53 (0.52) ALDH1A1HTTHPGDSMN1; SMN2MAPT
SCHEMBL27975917 0.74 TP53 (0.52) ALDH1A1HTTHPGDSMN1; SMN2MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5700826-A SENSITIZATION OF CANCER CELLS TO DRUG ONTOGEN CORPORATION (US) 1997-12-23 — — US disclosed
EP-0812829-A1 Substituted imidazoles as modulators of multi-drug resistance ONTOGEN CORPORATION (US) 1997-12-17 — — EP disclosed
Send feedback